| Financial Year |
March 31 2023 |
| Monetary Funds |
9,432,725,850.92 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
472,124,432.99 |
| Accounts Receivable |
6,586,854,551.45 |
| Advances to Suppliers |
206,073,698.44 |
| Other Receivables |
136,440,269.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,237,264,956.25 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
55,851,414.98 |
| Other Current Assets |
181,189,914.36 |
| Total Current Assets |
23,521,067,199.98 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
71,926,321.18 |
| Long-term Equity Investment |
411,893,002.49 |
| Investment Properties |
530,282,829.93 |
| Fixed Assetes |
3,515,055,438.44 |
| Under-construction Projects |
435,930,082.63 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,601,711,146.75 |
| R&D expenses |
56,148,324.92 |
| Goodwill |
211,051,596.84 |
| Long-Term Deferred and Prepaid Expenses |
271,854,529.46 |
| Deferred Income Tax Assets |
600,887,901.76 |
| Other Non-Current Assets |
107,868,097.18 |
| Sub-Total of Non-Current Assets |
8,580,544,113.36 |
| Total Assets |
32,101,611,313.34 |
| Short-Term Loans |
1,165,960,265.53 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,068,823,602.19 |
| Accounts Payable |
4,220,407,350.17 |
| Accounts Received In Advance |
564,900.03 |
| Employee Compensation Payable |
943,647,237.87 |
| Taxes Payable |
213,677,538.85 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
160,978,360.66 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,345,208,924.05 |
| Other Current Liabilities |
809,097,373.53 |
| Sub-Total of Current Liabilities |
13,273,979,823.49 |
| Long-term Loans |
2,273,090,287.94 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
124,791,638.59 |
| Deferred Income Tax Liabilities |
36,315,398.78 |
| Other Non-Current Liabilities |
254,304,413.87 |
| Sub-Total of Non-Current Liabilities |
2,961,587,457.17 |
| Total Liabilities |
16,235,567,280.66 |
| Paid-In Capital(Or Share Stock) |
1,052,122,527.00 |
| Capital Surplus |
2,843,874,430.10 |
| Surplus Reserve |
533,301,493.01 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
9,811,485,066.41 |
| Minority Stockholder's Interest |
1,473,468,630.33 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
14,392,575,402.35 |
| Owner's Equity（Stockholder's Equity） |
15,866,044,032.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
32,101,611,313.34 |
